Prostate Cancer: Is a PSA test worth the trouble?
Silver Cross hosts free lecture about Prostate Health on November 19
Joliet, IL (November 5, 2013)— Prostate cancer remains a leading cause of death among men, but when diagnosed early, can be treatable. The University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital is offering a lecture on prostate specific antigen (PSA) screenings that will educate area residents on whether getting screened is worth pursuing.
The prostate is a walnut-sized gland found only in men. It sits just below the bladder and surrounds the urethra, the tube that carries urine through the penis.
Dr. Daniel Golden, radiation oncologist with The University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, will present a free program titled Prostate Cancer: Is a PSA test worth the trouble? on Tuesday, Nov. 19, from 6:30 to 7:30 p.m. in the Silver Cross Hospital Conference Center, Pavilion A, 1890 Silver Cross Blvd., New Lenox.This program will discuss PSA (prostate specific antigen) screenings, over diagnosis, the cost of prostate cancer testing and treatment, and current treatment options that reduce but do not eliminate side effects. To register, visit www.silvercross.org or call 1-888-660-HEAL (4325).
“Prostate cancer is often slow-growing. And with enhanced cancer screenings, more patients are diagnosed in its earliest stages,” said Daniel W. Golden, M.D., radiation oncologist at the University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital in New Lenox. Dr. Golden is a specialist in the use of radiation-therapy to treat cancers of the central nervous system, head and neck, gastrointestinal tract, and genitourinary system.
“As a result, for many men—especially those who are older—the tumor does not progress enough to cause major problems during their lifetime.” Men should begin screening for prostate cancer at age 50, unless there is a family history of prostate cancer. Those men should be screened at age 40.
The screenings includes a digital rectal exam and blood test. Two simple methods are often used in screening for prostate cancer—a digital rectal exam (DRE), in which a doctor feels the prostate gland through the rectal wall, and a blood test, in which a blood sample is tested for the presence of a substance called prostate specific antigen (PSA).
Ways to Stay Protected
Although many prostate problems result from aging, here are some tips men can follow to stay healthy.
- A diet low in saturated fat and high in fruits and vegetables
- Good hygiene
- Ten grams of garlic or scallions daily (can be eaten raw or in vitamin form)
- Eating or drinking foods high in lycopene (an antioxidant found in tomatoes, tomato based products) and resveratrol (an antioxidant found in red grapes & wine)
- A healthy sex life/regular ejaculation (researchers say the ejaculation helps flush out carcinogenic substances)
About Daniel W. Golden, M.D.
Daniel W. Golden, M.D., radiation oncology physician, is a member of the care team at the University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital. A graduate of the University of California at Berkeley and the University of Illinois at Chicago College of Medicine, he completed his residency in radiation oncology and a fellowship in medical education at the University of Chicago. He joined the University of Chicago faculty as an assistant professor of radiation and cellular oncology in 2013. Dr. Golden is the co-author of more than 40 publications and scientific abstracts on the clinical applications of radiation therapy, and has received honors for his research dedication to teaching medical students. He is also a Level 3 alpine ski instructor, the highest certification offered by the Professional Ski Instructors of America, and is certified as an open-water SCUBA diver by the Professional Association of Diving Instructors. His office is located with the University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital at 1850 Silver Cross Blvd., New Lenox. To schedule an appointment, call (815) 300-1400.
About the University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital
The University of Chicago Medicine and Silver Cross Hospital’s outpatient cancer treatment center located in the Carolyn J. Czerkies Pavilion at I-355 and Route 6 (1850 Silver Cross Blvd.) in New Lenox opened its doors on June 25, 2012. The 20,000-square-foot University of Medicine Chicago Comprehensive Cancer Center at Silver Cross brings University of Chicago academic specialists and their advanced and investigational therapies into a community-hospital setting. The new facility provides state-of-the-art chemotherapy and radiation therapy, as well as access to hundreds of clinical trials. It also offers a TrueBeam new-generation linear accelerator system, which delivers precisely targeted radiation therapy to provide the best results. In addition, other services provided at the Comprehensive Cancer Center include cancer support services, hormonal therapy, immunotherapy, infusion services, and preventative screenings. The University of Chicago Medicine maintains more active clinical trials for the treatment of cancer than any other program in Illinois. To schedule an appointment, call 1-855-UCM-1400. For more information about the new University of Chicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, visit www.ucmcancer-sch.org.
About Silver Cross Hospital
Silver Cross Hospital is a not-for-profit health care provider serving Will County and southwest suburban communities since 1895. Silver Cross has been recognized as a Thomson Reuters 100 Top Hospitals National Award winner for seven consecutive years and as a Hospital of Choice by the American Alliance of Healthcare Providers. With over 3,000 employees, physicians and volunteers, Silver Cross operates a 289-bed acute care hospital and 9 satellite facilities providing outpatient services and physician offices. Silver Cross opened a state-of-the-art replacement hospital on February 26, 2012 at I-355 and Route 6 in New Lenox. To learn more about Silver Cross Hospital or a referral to a physician on staff, visit www.silvercross.org or call 1-888-660-HEAL (4325).
About The University of Chicago Medicine
The University of Chicago Medicine is home to world-class medical, research and teaching facilities where innovation has been a hallmark for decades. University of Chicago physician-scientists performed the first organ transplant and the first bone marrow transplant in animal models, the first successful living-donor liver transplant, the first hormone therapy for cancer and the first successful application of cancer chemotherapy. Its researchers also discovered REM sleep and were the first to describe several of the stages of sleep. Twelve of the 87 Nobel Prize winners associated with the University of Chicago have received the award for discoveries related to biology or medicine.
The University of Chicago Medicine’s Biological Sciences Division and the Medical Center work together under the University of Chicago Medicine brand to teach and train future physicians, perform research and practice patient care. The Medical Center ranks among the best in the country in cancer treatment, digestive disorders, diabetes and endocrinology, according to U.S. News & World Report’s survey of the nation’s hospitals. The University of Chicago Medicine’s Comer Children’s Hospital also is among the nation’s leading children’s hospitals, particularly in neonatology, gastroenterology and pulmonology. And the University of Chicago’s Pritzker School of Medicine was named one of the Top 10 medical schools in the United States in U.S. News’ 2012 graduate schools survey.